Appetite drops noticeably within 12 weeks
Headache or dizziness during the first few treatments
Kumari R, Silic MR, Jones-Hall YL, Nin-Velez A, Yang JY, Mittal SK, et al
Obesity-associated cardiac failure with retained ejection fraction (HFpEF) is a significant worldwide health concern, particularly among women
In the STEP and SUSTAIN clinical trial programmes, patients taking semaglutide at doses of 0.5mg to 1mg weekly achieved average weight reductions of 47% of their body weight over 6 to 12 months
Blend Composition PEPTIDE COMPONENTS BPC-157: 5mg (Body Protection Compound) GHK-Cu: 35mg (Copper Peptide) TB-500: 10mg (Thymosin Beta-4 Fragment) Ratio: 1:7:2 (BPC:GHK:TB) PHYSICAL PROPERTIES Total Weight: 50mg peptide blend Form: Lyophilized powder blend Color: Light blue tint (from GHK-Cu) Storage: Keep refrigerated 3646 F (28 C)